These stories add to the publics curiosity and debate over the matter
Speak with your provider if it remains persistent or severe
As described in the statistical analysis plan, for the single-dose part of the study, assuming an anti-GDF8 + anti-ActA combination treatment effect of 6% over placebo in thigh muscle volume by MRI and an anti-GDF8 alone treatment effect of 3% over placebo, sample sizes of 12 for the anti-GDF8 + anti-ActA combination, six for anti-GDF8 alone, and 12 for placebo (pooled) were estimated to provide 99% power in demonstrating a treatment difference between the anti-GDF8 + anti-ActA combination final dose and placebo at a two-sided 0.05 level based on an assumed common standard deviation of 3%
Healthcare providers may recommend compounded semaglutide injections during the maintenance phase of semaglutide therapy if the patient requires a dosage or formulation that isnt commercially available
Despite the similarly large decreases in body weight, the Sema group showed significant lean mass loss compared to the control group during the 4-week treatment period, while the Sema + -MSTN/-ActA group was not only protected against this lean mass loss, but also had a significant increase in lean mass (Fig
Better tolerance: Some patients cannot handle higher doses of weekly semaglutide
